Nanobiotix S.A. Anteile 2011-2026 | NBTX

Anteile Jährlich Nanobiotix S.A.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	34.7 B	24.4 M	-	-	-	-	-	-	-	-	-

Alle Zahlen in EUR-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
34.7 B	24.4 M	17.4 B

Anteile anderer Aktien in der Pharmaeinzelhändler

Name	Anteile	Preis	% 24h	Marktkapitalisierung	Land
MorphoSys AG MOR	33.4 M	-	2.43 %	$ 254 M	Germany
AgeX Therapeutics AGE	10.2 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	220 M	-	-	$ 866 M	China
Akero Therapeutics AKRO	67.1 M	-	-	$ 3.67 B	USA
Midatech Pharma plc MTP	80.5 M	-	-18.52 %	$ 27.3 M	Britain
AlloVir ALVR	15.3 M	-	4.14 %	$ 49.1 M	USA
Alexion Pharmaceuticals, Inc. ALXN	219 M	-	-	$ 40.3 B	USA
Aptorum Group Limited APM	7.35 M	$ 0.88	-1.69 %	$ 6.47 M	China
Biophytis SA BPTS	118 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	44.7 B	-	2.54 %	$ 160 B	France
Aquestive Therapeutics AQST	107 M	$ 4.1	1.23 %	$ 438 M	USA
ACADIA Pharmaceuticals ACAD	166 M	$ 22.45	1.13 %	$ 3.72 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	4.58 M	-	-1.52 %	$ 24.7 M	USA
Athira Pharma ATHA	4.28 M	-	-	$ 269 M	USA
Applied Molecular Transport AMTI	38.8 M	-	-	$ 10.1 M	USA
Ayala Pharmaceuticals AYLA	15.4 M	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	1.42 B	-	-	$ 96.9 B	Britain
Atreca BCEL	38.6 M	-	-11.76 %	$ 5.79 M	USA
Berkeley Lights BLI	68.9 M	-	-7.31 %	$ 87 M	USA
Calithera Biosciences CALA	73.9 M	-	-10.95 %	$ 876 K	USA
Advaxis ADXS	6.02 M	-	-9.65 %	$ 45.9 M	USA
CymaBay Therapeutics CBAY	106 M	-	-	$ 3.45 B	USA
ChemoCentryx CCXI	69.9 K	-	-	$ 3.74 B	USA
Cerus Corporation CERS	191 M	$ 2.03	5.73 %	$ 387 M	USA
Институт стволовых клеток человека ISKJ	75 M	-	-	-	Russia
Caladrius Biosciences CLBS	8.33 M	-	-16.75 %	$ 25.8 M	USA
Checkmate Pharmaceuticals CMPI	21.6 M	-	-	$ 231 M	USA
Kazia Therapeutics Limited KZIA	132 M	$ 13.64	9.82 %	$ 1.81 B	Australia
Aeterna Zentaris AEZS	115 M	-	5.93 %	$ 314 M	Canada
BioNTech SE BNTX	244 M	$ 103.45	1.85 %	$ 27.2 B	Germany
Brainstorm Cell Therapeutics BCLI	9.27 M	-	-2.5 %	$ 5.88 M	USA
Aeglea BioTherapeutics AGLE	78.2 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	45 M	-	-	$ 26.5 M	USA
Deciphera Pharmaceuticals DCPH	85.1 M	-	-	$ 2.18 B	USA
AIkido Pharma AIKI	14.3 M	-	1.93 %	$ 17.4 M	USA
Innate Pharma S.A. IPHA	79.5 M	$ 1.44	-3.36 %	$ 235 M	France
Dynavax Technologies Corporation DVAX	130 M	-	-	$ 2.02 B	USA
Akouos AKUS	34.4 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	86.8 M	-	-	$ 28.6 M	USA
Editas Medicine EDIT	88.7 M	$ 3.0	6.38 %	$ 266 M	USA
Edesa Biotech EDSA	3.2 M	$ 18.27	14.94 %	$ 58.4 M	USA
Can-Fite BioPharma Ltd. CANF	1.65 M	$ 3.19	6.69 %	$ 5.25 M	Israel
Eiger BioPharmaceuticals EIGR	1.48 M	-	-9.21 %	$ 2.55 M	USA
Eloxx Pharmaceuticals ELOX	2.17 M	-	-5.68 %	$ 8.28 M	USA
CureVac N.V. CVAC	186 M	-	-	$ 867 M	Germany
Ampio Pharmaceuticals AMPE	810 K	-	-11.43 %	$ 502 K	USA
Applied Therapeutics APLT	84.2 M	-	-	$ 8.42 M	USA
Aptose Biosciences APTO	2.45 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	67.7 M	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	36.4 M	-	-13.39 %	$ 1.45 M	USA